MLchartDataset catalogue

phase I/II clinical trial

Term · Oncology and biomedicine · MLC-T-ONC-006600

A study that tests the safety, side effects, and best dose of a new treatment. Phase I/II clinical trials also test how well a certain type of cancer or other disease responds to a new treatment. In the phase II part of the clinical trial, patients usually receive the highest dose of treatment that did not cause harmful side effects in the phase I part of the clinical trial. Combining phases I and II may allow research questions to be answered more quickly or with fewer patients. Also called phase 1/phase 2 clinical trial.

Table 1. Record
IdentifierMLC-T-ONC-006600
FieldOncology and biomedicine
Synonymsphase 1/phase 2 clinical trial
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006600",
  "term": "phase I/II clinical trial",
  "field": "Oncology and biomedicine",
  "definition": "A study that tests the safety, side effects, and best dose of a new treatment. Phase I/II clinical trials also test how well a certain type of cancer or other disease responds to a new treatment. In the phase II part of the clinical trial, patients usually receive the highest dose of treatment that did not cause harmful side effects in the phase I part of the clinical trial. Combining phases I and II may allow research questions to be answered more quickly or with fewer patients. Also called phase 1/phase 2 clinical trial.",
  "synonyms": [
    "phase 1/phase 2 clinical trial"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/phase-i-ii-clinical-trial/"
}

Record 13,095 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.